Sort   by:  
 Page size 
UnknownPRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.
Not available
S-EPMC7205431 | biostudies-literature
UnknownHedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function.
Not available
S-EPMC8026184 | biostudies-literature
UnknownSynthesis, biological evaluation, and radioiodination of halogenated closo-carboranylthymidine analogues.
Not available
S-EPMC3257809 | biostudies-literature
UnknownA Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Not available
S-EPMC10000669 | biostudies-literature
UnknownPreclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
Not available
S-EPMC7905592 | biostudies-literature
UnknownEffect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.
Not available
S-EPMC10786253 | biostudies-literature
UnknownPresence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study.
Not available
S-EPMC12447657 | biostudies-literature
UnknownComplete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone.
Not available
S-EPMC6050103 | biostudies-literature
UnknownCombination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.
Not available
S-EPMC3099572 | biostudies-literature
UnknownFTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.
Not available
S-EPMC3568700 | biostudies-literature
Sort   by:  
 Page size